FDA Approves First Biosimilar Cancer Drug

March 10, 2015 7:48 PM

14 0

The Federal Drug Administration approved the first biosimilar product in the United States on Friday. The drug, Zarxio, is now permitted for use in chemotherapy treatments to help patients' bodies produce white blood cells. Zarxio is the generic version of the biologic drug Neupogen.

Biologic drugs are larger and more complex than other pharmaceuticals, because they're built by living organisms--usually cells in a petri dish. Pharmaceutical companies typically patent those cellular factories, so generic companies have to use slightly different cells to make their drugs. The resu...

Read more

To category page